Healthcare staffing company AMN Healthcare Services (NYSE: AMN) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 99.9% year on year to $1.38 billion. On the other hand, next quarter’s revenue guidance of $627.5 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.10 per share was 29.9% above analysts’ consensus estimates.
Is now the time to buy AMN? Find out in our full research report (it’s free for active Edge members).
AMN Healthcare Services (AMN) Q1 CY2026 Highlights:
- Revenue: $1.38 billion vs analyst estimates of $1.23 billion (99.9% year-on-year growth, 11.8% beat)
- Adjusted EPS: $2.10 vs analyst estimates of $1.62 (29.9% beat)
- Adjusted EBITDA: $166.1 million vs analyst estimates of $122.6 million (12.1% margin, 35.5% beat)
- Revenue Guidance for Q2 CY2026 is $627.5 million at the midpoint, below analyst estimates of $635.6 million
- Operating Margin: 8.5%, up from 1.8% in the same quarter last year
- Sales Volumes rose 2.7% year on year (-22.1% in the same quarter last year)
- Market Capitalization: $867.8 million
StockStory’s Take
AMN Healthcare Services’ first quarter was marked by rapid scaling to support several large labor disruption events, a factor management described as a major operational milestone. CEO Caroline Grace credited the company’s technology investments and clinician network for enabling AMN to respond quickly and deliver high-touch service during these disruptions. She emphasized, “Our ability to move thousands of clinicians to meet urgent needs delivered great value on a scale we could not have done just a few years ago.” Management also highlighted improved performance in the core Nurse and Allied Staffing divisions, with the international staffing business returning to year-over-year growth.
Looking forward, AMN’s guidance reflects a normalization of revenue following the extraordinary impact of labor disruption events in the first quarter. Management expects ongoing investments in technology, workforce solutions, and operational efficiency to support the company’s transition toward more sustainable long-term growth. CFO Brian Scott noted, “We remain confident that we have the team and strategy to deliver leading tech-enabled solutions that will drive sustainable revenue growth with improved operating leverage.” The company is focused on expanding client relationships, leveraging AI tools, and driving cost discipline to navigate a more stable demand environment.
Key Insights from Management’s Remarks
Management attributed the quarter’s performance to substantial labor disruption revenue, technology-enabled execution, and early signs of recovery in core staffing and international business lines.
- Labor disruption services scaled: AMN handled five major labor disruption events in the quarter—three of which were large and two of indefinite duration. Management cited this as “historic for the industry” and credited years of planning and investment in technology for enabling the company to deliver rapid response and maintain client trust during high-stress periods.
- Core staffing momentum returns: Excluding labor disruption, Nurse and Allied Solutions achieved year-over-year volume growth for the first time since 2022. The travel nurse segment saw a 13% revenue increase, and the allied segment grew by 3%, supported by improved bill rates and demand stabilization.
- International staffing rebounds: The international staffing business posted its first year-over-year growth since late 2023, benefitting from progress on U.S. visa retrogression issues and an uptick in candidate approvals. Management expects high-teen percentage growth for the segment in the coming quarters, contingent on embassy processing speeds.
- Technology and AI boost efficiency: The WorkWise platform and AMN Passport app added new AI-powered features, including automated candidate scoring and supplier analytics. These updates reportedly improved fill rates and hiring efficiency, with Passport monthly active users up over 50% year-over-year.
- Competitive landscape consolidates: Management observed ongoing consolidation among staffing providers, noting that scale and technology are increasingly important. Some smaller and tech-enabled rivals have exited the market, while larger players are merging to better serve hospital clients seeking more comprehensive, cost-effective workforce solutions.
Drivers of Future Performance
AMN’s outlook for the next quarter is shaped by returning business normalization, stable demand in core segments, and ongoing investments in technology and operational efficiency.
- Labor disruption normalization: Management does not expect the exceptional level of labor disruption revenue seen in Q1 to recur, projecting a return to more typical revenue contributions from this segment. This normalization is expected to drive a sequential revenue decline, but highlights a more stable, predictable business mix moving forward.
- Tech-enabled staffing and cost control: The company is prioritizing technology-driven solutions, including AI tools for candidate matching and workforce planning, to improve fill rates and margin efficiency. Management believes these investments will enable adjusted EBITDA to grow at twice the pace of revenue once all service lines return to consistent growth.
- Industry consolidation and client focus: Ongoing consolidation in the healthcare staffing sector is expected to benefit larger, tech-enabled providers like AMN. Management sees opportunities to deepen client relationships through managed services programs and total talent solutions, while remaining attentive to cost management as hospital systems seek sustainable workforce strategies.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) the pace of normalization in labor disruption and rapid response activity, (2) continued volume and bill rate trends in Nurse, Allied, and international staffing, and (3) the adoption of AI-powered tools in driving fill rates and client wins. Execution on expanding managed services programs and progress on international visa processing will also be important signposts for sustainable growth.
AMN Healthcare Services currently trades at $26.88, up from $22.46 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
Now Could Be The Perfect Time To Invest In These Stocks
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
